PROF — Profound Medical Corp.
PROF dilution and offerings
- Active shelf: S-3 (May 2026)
- Float: 29.0M shares
$6.57+12.12%
Last close: · regular session
Last 60 sessions
Active shelf registration (S-3, May 2026). Float: 29.0M shares. Latest SEC filing: 8-K on Oct 22, 2026. PROF closed at $6.57 (+12.12%) on Oct 30, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for PROF in the TickerWise workspace.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: CA
- Exchange: NASDAQ
- Employees: 142
- Website: https://www.profoundmedical.com
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
Latest SEC filings for PROF
Latest PROF news
- Profound Medical expands U.S. sales network through Cook Medical partnership Read article
- Wall Street Analysts Believe Profound Medical (PROF) Could Rally 89.93%: Here's is How to Trade Read article
- Does Profound Medical (PROF) Have the Potential to Rally 58.77% as Wall Street Analysts Expect? Read article
- Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength? Read article
- Profound Medical expects Q3 revenue could top estimates by 47% Read article
- Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.